What is Cullinan Therapeutics, Inc. Common Stock's Market Cap?

Cullinan Therapeutics, Inc. Common Stock's Market Cap is $1.4B, based on as-reported figures from SEC (XBRL) filings.

What is Cullinan Therapeutics, Inc. Common Stock's Enterprise Value?

Cullinan Therapeutics, Inc. Common Stock's Enterprise Value is $1.1B, based on as-reported figures from SEC (XBRL) filings.

What is Cullinan Therapeutics, Inc. Common Stock's EV / EBITDA?

Cullinan Therapeutics, Inc. Common Stock's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.

What is Cullinan Therapeutics, Inc. Common Stock's Net Income (TTM)?

Cullinan Therapeutics, Inc. Common Stock's Net Income (TTM) is -$204.7M, based on as-reported figures from SEC (XBRL) filings.

What is Cullinan Therapeutics, Inc. Common Stock's EBITDA?

Cullinan Therapeutics, Inc. Common Stock's EBITDA is -$221.5M, based on as-reported figures from SEC (XBRL) filings.

What is Cullinan Therapeutics, Inc. Common Stock's Diluted EPS (TTM)?

Cullinan Therapeutics, Inc. Common Stock's Diluted EPS (TTM) is -3.18, based on as-reported figures from SEC (XBRL) filings.

What is Cullinan Therapeutics, Inc. Common Stock's Net Debt?

Cullinan Therapeutics, Inc. Common Stock's Net Debt is -$334.5M, based on as-reported figures from SEC (XBRL) filings.

Cullinan Therapeutics, Inc. Common Stock (CGEM) Financial Statements

Cullinan Therapeutics, Inc. Common Stock

SIC 2836 · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

FIGI BBG00HW2DGR3

XNAS · usd

21.69▼ 0.40 (-1.81%)

As of 2026-09-08

Valuation

Market Cap

Enterprise Value

Trailing P/E—

Price / Sales—

EV / Revenue—

EV / EBITDA

Financial Highlights

Revenue (TTM)—

Net Income (TTM)

EBITDA

Diluted EPS (TTM)

EBITDA Margin—

Net Debt

Trading Information

Previous Close22.09

Day's Range21.28 – 22.41

52-Week Range5.68 – 23.19

Volume950.2K

Avg Volume674.0K

Share Statistics

Shares Outstanding

Employees109

ExchangeXNAS

Listed2021-01-08

Share count as of July 31, 2026

ViewDetail

Period

Loading Income Statement…

Key questions about Cullinan Therapeutics, Inc. Common Stock (CGEM)

What is Cullinan Therapeutics, Inc. Common Stock's Market Cap?: Cullinan Therapeutics, Inc. Common Stock's Market Cap is $1.4B, based on as-reported figures from SEC (XBRL) filings.
What is Cullinan Therapeutics, Inc. Common Stock's Enterprise Value?: Cullinan Therapeutics, Inc. Common Stock's Enterprise Value is $1.1B, based on as-reported figures from SEC (XBRL) filings.
What is Cullinan Therapeutics, Inc. Common Stock's EV / EBITDA?: Cullinan Therapeutics, Inc. Common Stock's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.
What is Cullinan Therapeutics, Inc. Common Stock's Net Income (TTM)?: Cullinan Therapeutics, Inc. Common Stock's Net Income (TTM) is -$204.7M, based on as-reported figures from SEC (XBRL) filings.
What is Cullinan Therapeutics, Inc. Common Stock's EBITDA?: Cullinan Therapeutics, Inc. Common Stock's EBITDA is -$221.5M, based on as-reported figures from SEC (XBRL) filings.
What is Cullinan Therapeutics, Inc. Common Stock's Diluted EPS (TTM)?: Cullinan Therapeutics, Inc. Common Stock's Diluted EPS (TTM) is -3.18, based on as-reported figures from SEC (XBRL) filings.
What is Cullinan Therapeutics, Inc. Common Stock's Net Debt?: Cullinan Therapeutics, Inc. Common Stock's Net Debt is -$334.5M, based on as-reported figures from SEC (XBRL) filings.